|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||2.1150 - 2.2250|
|52-week range||2.1150 - 2.2250|
|Beta (5Y monthly)||1.87|
|PE ratio (TTM)||N/A|
|Earnings date||21 Mar 2022 - 25 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Investors need to pay close attention to Bionano (BNGO) stock based on the movements in the options market lately.
Bionano Genomics, BioCryst Pharmaceuticals, and NRx Pharmaceuticals all have the potential to make their early shareholders rich.
Leading the call today is Dr. Erik Holmlin, CEO of Bionano. Such forward-looking statements are based upon current expectations, and there can be no assurances that the results contemplated in these statements will be realized.